Published online before print April 21, 2008, doi: 10.1161/CIRCULATIONAHA.107.729368
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(Circulation. 2008;117:2192-2201.)
© 2008 American Heart Association, Inc.
Arrhythmia/Electrophysiology |
Long-QT Syndrome After Age 40
From the Cardiology Division of the Department of Medicine (I.G., A.J.M., J.B., S.P., S.M., W.Z., M.L.A., J.L.R.), Biostatistics and Computational Biology (D.R.P.), and Pathology (M.Q.), University of Rochester Medical Center, Rochester, NY; Departments of Medicine, Pediatrics, and Molecular Pharmacology (M.J.A.), Mayo Clinic College of Medicine, Rochester, Minn; Cardiovascular Department De Gasperis (E.H.L.), Niguarda Hospital, Milan, Italy; Bikur Cholim Hospital (J.B.), University of Jerusalem, Jerusalem, Israel; The Heart and Vascular Research Center (E.S.K.), MetroHealth Campus, Case Western Reserve University, Cleveland, Ohio; Molecular Cardiology (C.N., S.G.P.), Fondazione S. Maugeri–University of Pavia and the Department of Cardiology (P.J.S.), Fondazione Policlinico S. Matteo IRCCS and University of Pavia, Pavia, Italy; Department of Pediatric Cardiology (J.A.T.), Baylor College of Medicine, Houston, Tex; and Department of Medicine (G.M.V., L.Z.), University of Utah School of Medicine, Salt Lake City, Utah.
Correspondence to Ilan Goldenberg, MD, Heart Research Follow-Up Program, Box 653, University of Rochester Medical Center, Rochester, NY 14642. E-mail Ilan.Goldenberg{at}heart.rochester.edu
Received July 22, 2007; accepted January 29, 2008.
Background— Previous studies that assessed the risk of life-threatening cardiac events in patients with congenital long-QT syndrome (LQTS) have focused mainly on the first 4 decades of life, whereas the clinical course of this inherited cardiac disorder in the older population has not been studied.
Methods and Results— The risk of aborted cardiac arrest or death from age 41 though 75 years was assessed in 2759 subjects from the International LQTS Registry, categorized into electrocardiographically affected (corrected QT interval [QTc] 
470 ms), borderline (QTc 440 to 469 ms), and unaffected (QTc <440 ms) subgroups. The affected versus unaffected adjusted hazard ratio for aborted cardiac arrest or death was 2.65 (P<0.001) in the age range of 41 to 60 years and 1.23 (P=0.31) in the age range of 61 to 75 years. The clinical course of study subjects displayed gender differences: Affected LQTS women experienced a significantly higher cumulative event rate (26%) than borderline (16%) and unaffected (12%) women (P=0.001), whereas event rates were similar among the 3 respective subgroups of men (29%, 26%, and 27%; P=0.16). Recent syncope (<2 years in the past) was the predominant risk factor in affected subjects (hazard ratio 9.92, P<0.001), and the LQT3 genotype was identified as the most powerful predictor of outcome in a subset of 871 study subjects who were genetically tested for a known LQTS mutation (hazard ratio 4.76, P=0.02).
Conclusions— LQTS subjects maintain a high risk for life-threatening cardiac events after age 40 years. The phenotypic expression of affected subjects is influenced by age-specific factors related to gender, clinical history, and the LQTS genotype.
CLINICAL PERSPECTIVE
Related Article:
-
Clinical Summaries
Circulation 2008 117: 2169.[Extract] [Full Text]
This article has been cited by other articles:
 |
|
 |
|
  A. Winbo, U.-B. Diamant, E.-L. Stattin, S. M. Jensen, and A. Rydberg Low Incidence of Sudden Cardiac Death in a Swedish Y111C Type 1 Long-QT syndrome Population Circ Cardiovasc Genet, December 1, 2009; 2(6): 558 - 564. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Cerrone and S. G. Priori Routine electrocardiogram and medical history in syncope: a simple approach can identify most high-risk patients Europace, November 1, 2009; 11(11): 1411 - 1412. [Full Text] [PDF]
|
|
|
|
 |
|
 G. M. Marcus, E. Keung, and M. M. Scheinman The year in review of clinical cardiac electrophysiology. J. Am. Coll. Cardiol., August 25, 2009; 54(9): 777 - 787. [Full Text] [PDF]
|
|
|
|
|
|
E. S. Kaufman Disease-Causing Polymorphisms in the Spectrum of Long QT Syndrome Mutations. J. Am. Coll. Cardiol., August 25, 2009; 54(9): 820 - 821. [Full Text] [PDF]
|
|
|
|
|
|
N. Colman, A. Bakker, M. Linzer, J. B. Reitsma, W. Wieling, and A. A.M. Wilde Value of history-taking in syncope patients: in whom to suspect long QT syndrome? Europace, July 1, 2009; 11(7): 937 - 943. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. RAMARAJ Long QT syndrome: (AUGUST 2008) Cleveland Clinic Journal of Medicine, February 1, 2009; 76(2): 87 - 87. [Full Text] [PDF]
|
|
|
|
|
|
E. LEVINE and J. P. DAUBERT IN REPLY: Cleveland Clinic Journal of Medicine, February 1, 2009; 76(2): 88 - 88. [Full Text] [PDF]
|
|
|
|
 |
|
 L. Eckardt, G&#x.;n. Breithardt, and S. Hohnloser CHAPTER 30 Ventricular Tachycardia and Sudden Cardiac Death ESC Textbook of Cardiovascular Medicine, January 1, 2009; 2(1): med-9780199566990-chapter - med-9780199566990-chapter. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. J. Moss and I. Goldenberg Importance of Knowing the Genotype and the Specific Mutation When Managing Patients With Long-QT Syndrome Circ Arrhythm Electrophysiol, August 1, 2008; 1(3): 219 - 226. [Full Text] [PDF]
|
|
|
|
|
|
G. M. Vincent Genotyping Has a Minor Role in Selecting Therapy for Congenital Long-QT Syndromes at Present Circ Arrhythm Electrophysiol, August 1, 2008; 1(3): 227 - 233. [Full Text] [PDF]
|
|
|
|
 |
|
 C. I. Berul Congenital Long-QT Syndromes: Who's at Risk for Sudden Cardiac Death? Circulation, April 29, 2008; 117(17): 2178 - 2180. [Full Text] [PDF]
|
|